View ValuationTerrAscend 将来の成長Future 基準チェック /06TerrAscendは、34%と4.7%でそれぞれ年率34%で利益と収益が成長すると予測される一方、EPSはgrowで60.5%年率。主要情報34.0%収益成長率60.53%EPS成長率Pharmaceuticals 収益成長11.9%収益成長率4.7%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日08 May 2026今後の成長に関する最新情報お知らせ • Apr 29TerrAscend Corp. Provides Earnings Guidance for the First Quarter Ended March 31, 2026TerrAscend Corp. provided earnings guidance for the first quarter ended March 31, 2026. For the quarter, the company anticipates Net Revenue of $65.5 million, compared to $66.1 million in the fourth quarter of 2025 and $64.3 million in the first quarter of 2025.お知らせ • Nov 11TerrAscend Corp. Raises Earnings Guidance for 2023TerrAscend Corp. is raising its outlook for Net Revenue and Adjusted EBITDA from continuing operations for 2023 to $320 million and $73 million, respectively, representing year-over-year growth of 29% in Net Revenue and 87% in Adjusted EBITDA from continuing operations, respectively. The full year 2023 increase in guidance implies 2023 fourth quarter Net Revenue of $89 million and Adjusted EBITDA from continuing operations1 of $24 million.お知らせ • May 20TerrAscend Corp. Raises Earnings Guidance for the Full Year 2021TerrAscend Corp. raised earnings guidance for the full year 2021. The company is raising full year guidance and expects net sales to exceed USD 300 million compared to previous guidance of USD 290 million.お知らせ • Mar 24TerrAscend Corp. Provides Earnings Guidance for the Year of 2021TerrAscend Corp. provided earnings guidance for the year of 2021. For the year, the company expects net Sales to exceed USD 290 million.すべての更新を表示Recent updatesお知らせ • Apr 29TerrAscend Corp. Provides Earnings Guidance for the First Quarter Ended March 31, 2026TerrAscend Corp. provided earnings guidance for the first quarter ended March 31, 2026. For the quarter, the company anticipates Net Revenue of $65.5 million, compared to $66.1 million in the fourth quarter of 2025 and $64.3 million in the first quarter of 2025.お知らせ • Apr 27TerrAscend Corp. to Report Q1, 2026 Results on May 07, 2026TerrAscend Corp. announced that they will report Q1, 2026 results Pre-Market on May 07, 2026お知らせ • Apr 17TerrAscend Corp Appoints Eric Jackson as Chief Financial Officer, Effective April 27, 2026TerrAscend Corp. announced the appointment of Eric Jackson as Chief Financial Officer (“CFO”), effective April 27, 2026. Mr. Jackson brings more than two decades of finance and operational leadership experience across retail, consumer, and manufacturing sectors. Most recently, he served for over eight years as Executive Vice President and Chief Financial Officer of American Signature Inc., a multi-location, omnichannel retailer where Mr. Jackson oversaw finance, accounting, treasury, analytics, IT, real estate, and supply chain functions.Prior to American Signature, Mr. Jackson spent more than 14 years at L Brands, a publicly traded specialty retailer whose portfolio included Victoria’s Secret, PINK, Bath & Body Works, La Senza, and Henri Bendel. He held senior leadership roles across finance and operations, supporting its large-scale retail and merchandising businesses. Over the course of his career, Mr. Jackson has driven operational transformation, optimized cost structures, strengthened liquidity management, improved capital efficiency, and streamlined financial and operational processes to support long-term value creation. Mr. Jackson holds a Bachelor of Science in Business, from Miami University and a Master of Business Administration from The Ohio State University.お知らせ • Mar 17TerrAscend Corp., Annual General Meeting, Jun 09, 2026TerrAscend Corp., Annual General Meeting, Jun 09, 2026.お知らせ • Feb 10TerrAscend Corp. to Report Q4, 2025 Results on Mar 12, 2026TerrAscend Corp. announced that they will report Q4, 2025 results After-Market on Mar 12, 2026お知らせ • Oct 07TerrAscend Corp. to Report Q3, 2025 Results on Nov 06, 2025TerrAscend Corp. announced that they will report Q3, 2025 results After-Market on Nov 06, 2025お知らせ • Aug 20TerrAscend Corp. (TSX:TSND) announces an Equity Buyback for 10,000,000 shares, representing 3.27% for $10 million.TerrAscend Corp. (TSX:TSND) announces a share repurchase program. Under the program, the company will repurchase up to 10,000,000 shares, representing 3.27% of its issued share capital, for $10 million. All shares acquired will be returned to treasury and cancelled. The program ends no later than August 21, 2026. As of August 14, 2025, the company had 306,240,023 shares outstanding.お知らせ • Jul 10+ 1 more updateTerrAscend Corp. to Report Q2, 2025 Results on Aug 07, 2025TerrAscend Corp. announced that they will report Q2, 2025 results After-Market on Aug 07, 2025お知らせ • Jun 03TerrAscend Corp. Announces Executive Changes, Effective July 18, 2025TerrAscend Corp. announced that Keith Stauffer, Chief Financial Officer, will be departing the Company on July 18, 2025, to pursue a career opportunity outside of the cannabis industry. Mr. Stauffer will remain in his role through the transition period to ensure a smooth handover. Effective upon his departure, Alisa Campbell, currently Senior Vice President, Corporate Finance & Accounting, will assume leadership of the Company’s accounting and finance function on an interim basis, reporting to Ziad Ghanem, President and Chief Executive Officer. A comprehensive search for a permanent CFO is underway. Ms. Campbell, who joined TerrAscend in 2020, brings over 20 years of financial leadership experience. She worked closely with Mr. Stauffer and was integral in building the Company’s financial infrastructure, including the Company’s recent ERP implementation. Ms. Campbell has led many areas of financial management at the Company, including accounting, reporting, tax, treasury, FP&A, and operations.お知らせ • May 07TerrAscend Corp. (TSX:TSND) agreed to acquire Union Chill Cannabis Co LLC.TerrAscend Corp. (TSX:TSND) agreed to acquire Union Chill Cannabis Co LLC on May 6, 2025. The acquisition is expected to be immediately accretive to TerrAscend on an EBITDA and cashflow basis. The closing remains subject to regulatory approval.お知らせ • Apr 03TerrAscend Corp. to Report Q1, 2025 Results on May 08, 2025TerrAscend Corp. announced that they will report Q1, 2025 results After-Market on May 08, 2025お知らせ • Apr 02TerrAscend Corp., Annual General Meeting, Jun 24, 2025TerrAscend Corp., Annual General Meeting, Jun 24, 2025.お知らせ • Jan 31TerrAscend Corp. to Report Q4, 2024 Results on Mar 06, 2025TerrAscend Corp. announced that they will report Q4, 2024 results at 4:00 PM, US Eastern Standard Time on Mar 06, 2025お知らせ • Nov 27TerrAscend Corp. Appoints Lynn Gefen as Chief People OfficerTerrAscend Corp. announced the appointment of Lynn Gefen as Chief People Officer in addition to her existing role as Chief Legal Officer and Corporate Secretary, effective November 12, 2024. Prior to her roles at TerrAscend, Ms. Gefen served as Deputy General Counsel, Chief Risk and Compliance Officer, and Assistant Secretary at HomeServe, a publicly traded, independent provider of home repair service solutions. In addition to her roles at HomeServe, Ms. Gefen has worked for Diageo North America, a global leader in beverage alcohol, focusing on regulatory matters, privacy, and compliance, and for Citrix Systems, a multinational cloud computing and virtualization technology company, where she led a team with global responsibility for corporate and compliance matters including securities, commercial transactions, litigation, governance, and employment. Ms. Gefen began her legal career as an associate at Thacher Proffitt & Wood and Holland & Knight. Ms. Gefen received a J.D. from American University and a Bachelor of Arts from the University of Florida.お知らせ • Oct 08TerrAscend Corp. to Report Q3, 2024 Results on Nov 06, 2024TerrAscend Corp. announced that they will report Q3, 2024 results After-Market on Nov 06, 2024お知らせ • Oct 02TerrAscend Corp. announced that it has received $140 million in funding from Wdb Holding Ca, Inc., Wdb Holding PA Inc, FocusGrowth Asset Management, LP, Hempaid, LLC, Moose Curve Holdings, LLC and other investorsOn September 30, 2024, TerrAscend Corp. closed the transaction. As on the same day, the company has received $26 million in it's second and final tranche.お知らせ • Aug 21TerrAscend Corp. (TSX:TSND) announces an Equity Buyback for 10,000,000 shares, representing 3.43% for $10 million.TerrAscend Corp. (TSX:TSND) announces a share repurchase program. Under the program, the company will repurchase up to 10,000,000 shares, representing 3.43% of its issued share capital, for $10 million. All shares acquired will be returned to treasury and cancelled. The program ends no later than August 21, 2025. As of August 16, 2024, the company had 291,513,055 shares outstanding.お知らせ • Jul 11TerrAscend Corp. to Report Q2, 2024 Results on Aug 08, 2024TerrAscend Corp. announced that they will report Q2, 2024 results After-Market on Aug 08, 2024お知らせ • Apr 26Terrascend Corp. Launches Legend Mini Pre-Roll Packs in New JerseyTerrAscend Corp. announced that Legend will launch its first mini pre-roll pack. Beginning April 26, these bundles will be available exclusively at Apothecarium dispensaries in New Jersey while landing across the rest of the New Jersey market starting April 29. Adult-use consumers and patients searching for an alternative to the traditional pre-roll can embark on their next unforgettable cannabis adventure with any one of the brand's convenient packs, including Energized Legend (Sativa), Grounded Legend (Hybrid) or Zen Legend (Indica). Each set contains eight 0.375g pre-rolls with blends combining two to three strains, bringing out richer and more distinct terpene profiles. The Legend mini pre-roll collection builds upon TerrAscend's commitment to providing patients and adult-use consumers across New Jersey with innovative and carefully crafted cannabis products to enhance the everyday. The Company operates a cultivation and manufacturing facility in Boonton, New Jersey, and distributes its products via wholesale throughout the state in more than 100 dispensaries in addition to running its own three retail locations: Apothecarium Lodi, Apothecarium Maplewood, and Apothecarium Phillipsburg.お知らせ • Apr 05TerrAscend Corp. to Report Q1, 2024 Results on May 09, 2024TerrAscend Corp. announced that they will report Q1, 2024 results After-Market on May 09, 2024お知らせ • Feb 21TerrAscend Corp. to Report Fiscal Year 2023 Results on Mar 14, 2024TerrAscend Corp. announced that they will report fiscal year 2023 results After-Market on Mar 14, 2024お知らせ • Jan 24TerrAscend Corp. Announces the Expansion of its Valhalla Product Offering to Include One of the First 100Mg Edibles in the Keystone StateTerrAscend Corp. announced the expansion of its Valhalla product offering to include one of the first 100mg edibles in The Keystone State. Valhalla's 100mg quick-acting, high-potency troches will land on store shelves on February 2nd. The Valhalla Extra Strength Troches will be available at all Apothecarium locations and additional dispensaries throughout Pennsylvania. The innovative Valhalla Troches first debuted in Pennsylvania last fall, quickly becoming a patient favorite. Currently available in 5mg, 10mg, and 50mg of THC flavor-forward varieties, including Blue Raspberry (Indica), Orange (Sativa), and Watermelon (Hybrid), Valhalla Troches are supplied in convenient, resealable packaging optimal for patients on the go. The new 100mg troches will be available in Grape (Indica), Pineapple (Sativa), and Green Apple (Hybrid).お知らせ • Nov 11TerrAscend Corp. Raises Earnings Guidance for 2023TerrAscend Corp. is raising its outlook for Net Revenue and Adjusted EBITDA from continuing operations for 2023 to $320 million and $73 million, respectively, representing year-over-year growth of 29% in Net Revenue and 87% in Adjusted EBITDA from continuing operations, respectively. The full year 2023 increase in guidance implies 2023 fourth quarter Net Revenue of $89 million and Adjusted EBITDA from continuing operations1 of $24 million.お知らせ • Oct 24TerrAscend Corp. to Report Q3, 2023 Results on Nov 09, 2023TerrAscend Corp. announced that they will report Q3, 2023 results After-Market on Nov 09, 2023お知らせ • Aug 11+ 1 more updateTerrAscend Corp. Reports Impairment for the Second Quarter Ended June 30, 2023TerrAscend Corp. reported impairment results for the second quarter ended June 30, 2023. For the quarter, the company reported Impairment of property and equipment of $10,000.お知らせ • Aug 03TerrAscend Corp. to Report Q2, 2023 Results on Aug 10, 2023TerrAscend Corp. announced that they will report Q2, 2023 results After-Market on Aug 10, 2023お知らせ • Jul 11TerrAscend Corp. (CNSX:TER) acquired Herbiculture Inc. for $8.25 million.TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Herbiculture Inc. for $8.25 million on June 29, 2023. Under the terms of the agreement, TerrAscend will acquire Herbiculture for total consideration of $8.25 million (the "Transaction"), composed of $3 million in cash, with the remainder in a seller’s note. The transaction, which is expected to be immediately accretive to TerrAscend on an EBITDA and cashflow basis, has already been approved by the Maryland Cannabis Administration and is expected to close in the coming days. Herbiculture has a net revenue run rate of approximately $4.3 million. TerrAscend Corp. (CNSX:TER) completed the acquisition of Herbiculture Inc. on July 10, 2023.お知らせ • Jun 29TerrAscend Corp. (CNSX:TER) completed the acquisition of Derby 1, LLC.TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Derby 1, LLC for $22.1 million on June 7, 2023. Under the terms of the agreement, TerrAscend will acquire Peninsula Alternative Health for total consideration of $22.1 million, including $1.5 million in cash, with the remainder in a combination of existing debt, a seller’s note, and stock. The transaction, which is expected to be immediately accretive to TerrAscend on an EBITDA and cashflow basis, is subject to customary closing conditions, including regulatory approval. As of June 19, 2023 regulatory board approved the deal. The acquisition is expected to close shortly. The transaction is expected to be immediately accretive to TerrAscend on an EBITDA and cashflow basis. TerrAscend Corp. (CNSX:TER) completed the acquisition of Derby 1, LLC on June 28, 2023.お知らせ • Jun 28TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Hempaid, LLC for $6.8 million.TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Hempaid, LLC for $6.8 million on June 26, 2023. Under the terms of the agreement, TerrAscend will acquire Blue Ridge Wellness for total consideration of $6.75 million, including $3 million in cash, with the remainder in a seller’s note. Following the close of the Transaction, TerrAscend's retail footprint will increase to 36 dispensaries nationwide.お知らせ • Jun 23TerrAscend Corp. announced that it expects to receive $15 million in fundingTerrAscend Corp. announced two concurrent private placements for the aggregate gross proceeds of $15 million. The private placements consist of an equity offering of up to 5,000,000 units at a price of $2 per unit for the gross proceeds of $7.5 million. Each unit is comprised of one common share of the Company and one-half of one Common Share purchase warrant. Each warrant will entitle the holder to acquire one common share from the company at a price of $1.95 per common share for a period of 24 months following the closing of the equity offering. The company is also offering approximately $7.5 million of debentures in the principal amount of $1,000 per debenture. Unless earlier repaid or converted, the outstanding principal and accrued and unpaid interest on the debentures will be due and payable 36 months following the closing of the debenture offering. Each debenture will bear interest at a rate of 9.9% per annum from the date of issuance, calculated and compounded semi-annually, and payable on the maturity date. The securities offered pursuant to the private placements have not been and will not be registered under the U.S. Securities Act of 1933, as amended. The first closing is expected to occur on June 22, 2023.お知らせ • Jun 10TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Derby 1, LLC for $22.1 million.TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Derby 1, LLC for $22.1 million on June 7, 2023. Under the terms of the agreement, TerrAscend will acquire Peninsula Alternative Health for total consideration of $22.1 million, including $1.5 million in cash, with the remainder in a combination of existing debt, a seller’s note, and stock. The transaction, which is expected to be immediately accretive to TerrAscend on an EBITDA and cashflow basis, is subject to customary closing conditions, including regulatory approval.お知らせ • May 24An unknown buyer acquired Facility located in Mississauga, Canada from TerrAscend Corp. (CNSX:TER) for CAD19.7 million.An unknown buyer acquired Facility located in Mississauga, Canada from TerrAscend Corp. (CNSX:TER) for CAD19.7 million on May 23, 2023.An unknown buyer completed the acquisition of Facility located in Mississauga, Canada from TerrAscend Corp. (CNSX:TER) on May 23, 2023.お知らせ • Feb 15Terrascend Appoints Jeroen De Beijer as Chief People and Culture OfficerTerrAscend Corp. announced the appointment of Jeroen De Beijer as Chief People and Culture Officer, effective immediately. De Beijer brings more than 20 years of experience in global human resources and people management operations. De Beijer will manage TerrAscend's overall People team and strategy helping the Company scale all elements of its People organization, including culture, organizational design, talent acquisition, employee experience, operational efficiency and more. Most recently, DeBeijer worked as Vice President, Human Resources for Operations at Refresco, the world largest independent bottling company. In this role DeBeijer oversaw all Human Resources activities for Refresco North America's manufacturing facilities in the United States and Canada. DeBeijer transitioned into this role from his previous role in Refresco at their corporate head office in the Netherlands where he oversaw several international Human Resources projects and supported Refresco's Executive Board. Prior to his role at Refresco, DeBeijer owned his own consulting business focusing on Human Resources projects at large companies in the manufacturing and services industry. He also worked in leadership roles for Delta Lloyd, a large insurance company in the Netherlands, CapGemini Consulting and Nationale - Nederlanden, a large European Insurance company. DeBeijer began his Human Resources career as a consultant at Hay Group (now Korn/Ferry). Born in the Netherlands, DeBeijer received a master's degree in corporate and employment law from Utrecht University in the Netherlands.お知らせ • Sep 03+ 1 more updateTerrAscend Corp. Brings its Premium California Brand, Valhalla Confections, to New JerseyTerrAscend Corp. announced the East Coast launch of its premium edibles brand Valhalla Confections. The THC-infused soft lozenges (the "soft lozenges") are exclusively available at the Company's two New Jersey Apothecarium dispensaries located in Maplewood and Phillipsburg. Valhalla's soft lozenges gained popularity on the West Coast as one of the first precisely dosed ingestible products on the market. The lozenges are gluten-free and formulated with THC oil, terpenes and cannabinoids to deliver precise, discreet and convenient cannabis experiences. At launch, New Jersey medical patients will have access to three of the brand's most popular flavors: Blue Raspberry, Sour Watermelon and Sweet Orange. Each package contains 35 lozenges, providing 10mg of THC per lozenge.お知らせ • Aug 21TerrAscend Corp. (CNSX:TER) acquired an additional 12.5% stake in TerrAscend NJ LLC from Blue Marble Ventures, LLC and BWH NJ, LLC for $50 million.TerrAscend Corp. (CNSX:TER) acquired an additional 12.5% stake in TerrAscend NJ LLC from Blue Marble Ventures, LLC and BWH NJ, LLC for $50 million on August 20, 2021. As a part of the transaction, an initial cash payment of $25 million with an additional $25 million payment comprised of a combination of cash and common shares to be paid on or before December 31, 2021. As a result, the TerrAscend now owns 87.5% of the issued and outstanding equity of TerrAscend New Jersey. In addition, the TerrAscend and the sellers have agreed to terms whereby TerrAscend will have the option to purchase an additional 6.25% of TerrAscend New Jersey. TerrAscend Corp. (CNSX:TER) completed the acquisition of an additional 12.5% stake in TerrAscend NJ LLC from Blue Marble Ventures, LLC and BWH NJ, LLC on August 20, 2021.お知らせ • May 20TerrAscend Corp. Raises Earnings Guidance for the Full Year 2021TerrAscend Corp. raised earnings guidance for the full year 2021. The company is raising full year guidance and expects net sales to exceed USD 300 million compared to previous guidance of USD 290 million.お知らせ • May 04TerrAscend Corp. (CNSX:TER) completed the acquisition of GuadCo, LLC and KCR Holdings, LLC.TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire remaining 90% stake in GuadCo, LLC and KCR Holdings, LLC for $63 million on April 20, 2021. The consideration is comprised of $36 million in stock, $20.25 million in cash and a $6.75 million note. TerrAscend currently owns 10% of GuadCo and KCR. The purchase price is expected to represent a mid-single digit multiple of GuadCo and KCR's 2021 EBITDA. Upon close, the transaction will add three retail dispensaries located in Bethlehem, Allentown and Stroudsburg to complement TerrAscend’s existing retail footprint in Southeastern Pennsylvania. The transaction is subject to customary regulatory approvals and is expected to occur in the second quarter of 2021 and will be immediately accretive upon closing. TerrAscend Corp. (CNSX:TER) completed the acquisition of GuadCo, LLC and KCR Holdings, LLC on May 3, 2021.お知らせ • Mar 24TerrAscend Corp. Provides Earnings Guidance for the Year of 2021TerrAscend Corp. provided earnings guidance for the year of 2021. For the year, the company expects net Sales to exceed USD 290 million.お知らせ • Feb 20TerrAscend Corp. to Report Q4, 2020 Results on Mar 23, 2021TerrAscend Corp. announced that they will report Q4, 2020 results on Mar 23, 2021お知らせ • Jan 13TerrAscend Corp. announced that it expects to receive CAD 223.727944 million in funding from Wasatch Advisors Inc.TerrAscend Corp. (CNSX:TER) announced an oversubscribed non-brokered private placement of 18,115,623 common shares at a price of CAD 12.35 per share gross proceeds of CAD 223,727,944 on January 12, 2021. The transaction includes 80% of commitment from four large U.S. institutional investors including Wasatch Advisors Inc. The transaction is subject to customary closing conditions, including applicable CSE approvals. The transaction is expected to close on or about January 26, 2021.お知らせ • Nov 25TerrAscend Corp. Receives Permit to Dispense Medical Cannabis at its First New Jersey DispensaryTerrAscend Corp. ('TerrAscend') announced that it has received the final permit from the NJ Department of Health ("NJ DOH") to dispense medical cannabis from its first dispensary in New Jersey. The 3,500 square-foot dispensary, located at 55 South Main Street in downtown Phillipsburg, is situated in the historic Phillipsburg National Bank & Trust building and is the first Alternative Treatment Center ('ATC') in Warren County. The Apothecarium Phillipsburg will commence serving medical patients, by appointment only, followed by an official grand opening on November 30, 2020. The new full service medical dispensary offers a broad range of patient education resources, including multiple private consultation rooms and highly trained wellness consultation staff to assist patients and caregivers. TerrAscend operates a cultivation and manufacturing facility located in Boonton, New Jersey (the 'Boonton Facility') and expects to open three ATC's in the Northern region of New Jersey. New Jersey, which recently voted to legalize a forthcoming adult-use cannabis program, is the 11th large state in the U.S. by population, with nearly 9 million residents, and more than 94,000 registered medical cannabis patients. The Company expects to open the remaining two ATCs, or dispensaries in 2021 upon regulatory approval. The Northern region of New Jersey has the higher density of patients in the state, and TerrAscend is one of four permit holders. The Apothecarium Phillipsburg offers a wide variety of medical cannabis products, including dried flower, vaporizable and activated oils, pre-rolls, capsules, tinctures, topicals, and a comprehensive selection of smoking and ancillary products. Additionally, the new dispensary carries TerrAscend's recently launched Kind Tree branded cannabis products grown at the Company's Boonton Facility. Like other Apothecarium stores, the modern, tech-forward aesthetic is designed to be both comfortable and easy to navigate for seniors, first-time dispensary visitors, and patients with serious medical conditions. To comply with new state COVID-19 restrictions and CDC guidelines, in-person visits require pre-registration and only patients with appointments are permitted to shop in the store. The dispensary also offers online ordering and in-store pickup, with curbside pickup and delivery service launching shortly. All Apothecarium dispensaries have implemented strict safety standards to protect guests and team members. The Company's New Jersey safety protocols include strict social distancing inside and outside the dispensaries, a mask requirement for everyone inside the dispensaries, no contact check-in procedures and ongoing sanitizing throughout the day.お知らせ • Nov 04TerrAscend Corp. to Report Q3, 2020 Results on Nov 19, 2020TerrAscend Corp. announced that they will report Q3, 2020 results at 12:27 PM, GMT Standard Time on Nov 19, 2020お知らせ • Nov 03TerrAscend Corp. Announces Appointment of Ed Schutter to Its Board of DirectorsTerrAscend Corp. announced the appointment of Ed Schutter to its Board of Directors. Mr. Schutter is a seasoned executive with over thirty years of pharmaceutical industry experience. He currently serves as Chief Executive Officer of Arbor Pharmaceuticals. Arbor also has several branded prescription products in late stage development. Prior to joining Arbor, Ed served as President of Sciele (Shionogi) Pharmaceuticals.お知らせ • Aug 22TerrAscend Corp. announced that it has received $37 million in funding from JW Asset Management, LLCIn the second quarter of 2020, TerrAscend Corp. (CNSX:TER) closed the transaction. The company received $2,586,000 in its final tranche.お知らせ • Aug 07TerrAscend Corp. to Report Q2, 2020 Results on Aug 20, 2020TerrAscend Corp. announced that they will report Q2, 2020 results at 12:27 PM, GMT Standard Time on Aug 20, 2020業績と収益の成長予測OTCPK:TSND.F - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2028290N/AN/AN/A112/31/2027281-152332312/31/2026265-20182733/31/2026262-281522N/A12/31/2025261-291222N/A9/30/2025299-71823N/A6/30/2025300-771123N/A3/31/2025302-782133N/A12/31/2024268-283038N/A9/30/2024288-813038N/A6/30/2024312-743544N/A3/31/2024317-812132N/A12/31/2023251-362127N/A9/30/2023300-50325N/A6/30/2023277-342-618N/A3/31/2023269-311-351N/A12/31/2022248-304-69-26N/A9/30/2022212-298-77-37N/A6/30/202219559-100-57N/A3/31/202218913-94-57N/A12/31/202119413-72-32N/A9/30/2021211-96-114-70N/A6/30/2021200-165-102-53N/A3/31/2021175-144-78-30N/A12/31/2020132-125-82-37N/A9/30/2020118-159-47-1N/A6/30/202099-156-41-2N/A3/31/202075-155-58-25N/A12/31/201964-161N/A-40N/A9/30/201948-44N/A-32N/A6/30/201930-33N/A-33N/A3/31/201916-23N/A-26N/A12/31/20185-16N/A-20N/A9/30/20181-9N/A-21N/A6/30/20180-8N/A-17N/A3/31/2018N/A-7N/A-6N/A12/31/2017N/A-5N/A-3N/A9/30/2017N/A-5N/A-3N/A6/30/2017N/A-4N/A0N/A3/31/2017N/A-1N/A-1N/A12/31/2016N/A-1N/A0N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: TSND.F今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: TSND.F今後 3 年間、利益が出ない状態が続くと予測されています。高成長収益: TSND.F今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: TSND.Fの収益 ( 4.7% ) US市場 ( 11.7% ) よりも低い成長が予測されています。高い収益成長: TSND.Fの収益 ( 4.7% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: TSND.Fの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/15 06:32終値2026/05/15 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋TerrAscend Corp. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。9 アナリスト機関Frederico Yokota Choucair GomesATB CormarkMatt BottomleyCanaccord GenuityShaan MirCanaccord Genuity6 その他のアナリストを表示
お知らせ • Apr 29TerrAscend Corp. Provides Earnings Guidance for the First Quarter Ended March 31, 2026TerrAscend Corp. provided earnings guidance for the first quarter ended March 31, 2026. For the quarter, the company anticipates Net Revenue of $65.5 million, compared to $66.1 million in the fourth quarter of 2025 and $64.3 million in the first quarter of 2025.
お知らせ • Nov 11TerrAscend Corp. Raises Earnings Guidance for 2023TerrAscend Corp. is raising its outlook for Net Revenue and Adjusted EBITDA from continuing operations for 2023 to $320 million and $73 million, respectively, representing year-over-year growth of 29% in Net Revenue and 87% in Adjusted EBITDA from continuing operations, respectively. The full year 2023 increase in guidance implies 2023 fourth quarter Net Revenue of $89 million and Adjusted EBITDA from continuing operations1 of $24 million.
お知らせ • May 20TerrAscend Corp. Raises Earnings Guidance for the Full Year 2021TerrAscend Corp. raised earnings guidance for the full year 2021. The company is raising full year guidance and expects net sales to exceed USD 300 million compared to previous guidance of USD 290 million.
お知らせ • Mar 24TerrAscend Corp. Provides Earnings Guidance for the Year of 2021TerrAscend Corp. provided earnings guidance for the year of 2021. For the year, the company expects net Sales to exceed USD 290 million.
お知らせ • Apr 29TerrAscend Corp. Provides Earnings Guidance for the First Quarter Ended March 31, 2026TerrAscend Corp. provided earnings guidance for the first quarter ended March 31, 2026. For the quarter, the company anticipates Net Revenue of $65.5 million, compared to $66.1 million in the fourth quarter of 2025 and $64.3 million in the first quarter of 2025.
お知らせ • Apr 27TerrAscend Corp. to Report Q1, 2026 Results on May 07, 2026TerrAscend Corp. announced that they will report Q1, 2026 results Pre-Market on May 07, 2026
お知らせ • Apr 17TerrAscend Corp Appoints Eric Jackson as Chief Financial Officer, Effective April 27, 2026TerrAscend Corp. announced the appointment of Eric Jackson as Chief Financial Officer (“CFO”), effective April 27, 2026. Mr. Jackson brings more than two decades of finance and operational leadership experience across retail, consumer, and manufacturing sectors. Most recently, he served for over eight years as Executive Vice President and Chief Financial Officer of American Signature Inc., a multi-location, omnichannel retailer where Mr. Jackson oversaw finance, accounting, treasury, analytics, IT, real estate, and supply chain functions.Prior to American Signature, Mr. Jackson spent more than 14 years at L Brands, a publicly traded specialty retailer whose portfolio included Victoria’s Secret, PINK, Bath & Body Works, La Senza, and Henri Bendel. He held senior leadership roles across finance and operations, supporting its large-scale retail and merchandising businesses. Over the course of his career, Mr. Jackson has driven operational transformation, optimized cost structures, strengthened liquidity management, improved capital efficiency, and streamlined financial and operational processes to support long-term value creation. Mr. Jackson holds a Bachelor of Science in Business, from Miami University and a Master of Business Administration from The Ohio State University.
お知らせ • Mar 17TerrAscend Corp., Annual General Meeting, Jun 09, 2026TerrAscend Corp., Annual General Meeting, Jun 09, 2026.
お知らせ • Feb 10TerrAscend Corp. to Report Q4, 2025 Results on Mar 12, 2026TerrAscend Corp. announced that they will report Q4, 2025 results After-Market on Mar 12, 2026
お知らせ • Oct 07TerrAscend Corp. to Report Q3, 2025 Results on Nov 06, 2025TerrAscend Corp. announced that they will report Q3, 2025 results After-Market on Nov 06, 2025
お知らせ • Aug 20TerrAscend Corp. (TSX:TSND) announces an Equity Buyback for 10,000,000 shares, representing 3.27% for $10 million.TerrAscend Corp. (TSX:TSND) announces a share repurchase program. Under the program, the company will repurchase up to 10,000,000 shares, representing 3.27% of its issued share capital, for $10 million. All shares acquired will be returned to treasury and cancelled. The program ends no later than August 21, 2026. As of August 14, 2025, the company had 306,240,023 shares outstanding.
お知らせ • Jul 10+ 1 more updateTerrAscend Corp. to Report Q2, 2025 Results on Aug 07, 2025TerrAscend Corp. announced that they will report Q2, 2025 results After-Market on Aug 07, 2025
お知らせ • Jun 03TerrAscend Corp. Announces Executive Changes, Effective July 18, 2025TerrAscend Corp. announced that Keith Stauffer, Chief Financial Officer, will be departing the Company on July 18, 2025, to pursue a career opportunity outside of the cannabis industry. Mr. Stauffer will remain in his role through the transition period to ensure a smooth handover. Effective upon his departure, Alisa Campbell, currently Senior Vice President, Corporate Finance & Accounting, will assume leadership of the Company’s accounting and finance function on an interim basis, reporting to Ziad Ghanem, President and Chief Executive Officer. A comprehensive search for a permanent CFO is underway. Ms. Campbell, who joined TerrAscend in 2020, brings over 20 years of financial leadership experience. She worked closely with Mr. Stauffer and was integral in building the Company’s financial infrastructure, including the Company’s recent ERP implementation. Ms. Campbell has led many areas of financial management at the Company, including accounting, reporting, tax, treasury, FP&A, and operations.
お知らせ • May 07TerrAscend Corp. (TSX:TSND) agreed to acquire Union Chill Cannabis Co LLC.TerrAscend Corp. (TSX:TSND) agreed to acquire Union Chill Cannabis Co LLC on May 6, 2025. The acquisition is expected to be immediately accretive to TerrAscend on an EBITDA and cashflow basis. The closing remains subject to regulatory approval.
お知らせ • Apr 03TerrAscend Corp. to Report Q1, 2025 Results on May 08, 2025TerrAscend Corp. announced that they will report Q1, 2025 results After-Market on May 08, 2025
お知らせ • Apr 02TerrAscend Corp., Annual General Meeting, Jun 24, 2025TerrAscend Corp., Annual General Meeting, Jun 24, 2025.
お知らせ • Jan 31TerrAscend Corp. to Report Q4, 2024 Results on Mar 06, 2025TerrAscend Corp. announced that they will report Q4, 2024 results at 4:00 PM, US Eastern Standard Time on Mar 06, 2025
お知らせ • Nov 27TerrAscend Corp. Appoints Lynn Gefen as Chief People OfficerTerrAscend Corp. announced the appointment of Lynn Gefen as Chief People Officer in addition to her existing role as Chief Legal Officer and Corporate Secretary, effective November 12, 2024. Prior to her roles at TerrAscend, Ms. Gefen served as Deputy General Counsel, Chief Risk and Compliance Officer, and Assistant Secretary at HomeServe, a publicly traded, independent provider of home repair service solutions. In addition to her roles at HomeServe, Ms. Gefen has worked for Diageo North America, a global leader in beverage alcohol, focusing on regulatory matters, privacy, and compliance, and for Citrix Systems, a multinational cloud computing and virtualization technology company, where she led a team with global responsibility for corporate and compliance matters including securities, commercial transactions, litigation, governance, and employment. Ms. Gefen began her legal career as an associate at Thacher Proffitt & Wood and Holland & Knight. Ms. Gefen received a J.D. from American University and a Bachelor of Arts from the University of Florida.
お知らせ • Oct 08TerrAscend Corp. to Report Q3, 2024 Results on Nov 06, 2024TerrAscend Corp. announced that they will report Q3, 2024 results After-Market on Nov 06, 2024
お知らせ • Oct 02TerrAscend Corp. announced that it has received $140 million in funding from Wdb Holding Ca, Inc., Wdb Holding PA Inc, FocusGrowth Asset Management, LP, Hempaid, LLC, Moose Curve Holdings, LLC and other investorsOn September 30, 2024, TerrAscend Corp. closed the transaction. As on the same day, the company has received $26 million in it's second and final tranche.
お知らせ • Aug 21TerrAscend Corp. (TSX:TSND) announces an Equity Buyback for 10,000,000 shares, representing 3.43% for $10 million.TerrAscend Corp. (TSX:TSND) announces a share repurchase program. Under the program, the company will repurchase up to 10,000,000 shares, representing 3.43% of its issued share capital, for $10 million. All shares acquired will be returned to treasury and cancelled. The program ends no later than August 21, 2025. As of August 16, 2024, the company had 291,513,055 shares outstanding.
お知らせ • Jul 11TerrAscend Corp. to Report Q2, 2024 Results on Aug 08, 2024TerrAscend Corp. announced that they will report Q2, 2024 results After-Market on Aug 08, 2024
お知らせ • Apr 26Terrascend Corp. Launches Legend Mini Pre-Roll Packs in New JerseyTerrAscend Corp. announced that Legend will launch its first mini pre-roll pack. Beginning April 26, these bundles will be available exclusively at Apothecarium dispensaries in New Jersey while landing across the rest of the New Jersey market starting April 29. Adult-use consumers and patients searching for an alternative to the traditional pre-roll can embark on their next unforgettable cannabis adventure with any one of the brand's convenient packs, including Energized Legend (Sativa), Grounded Legend (Hybrid) or Zen Legend (Indica). Each set contains eight 0.375g pre-rolls with blends combining two to three strains, bringing out richer and more distinct terpene profiles. The Legend mini pre-roll collection builds upon TerrAscend's commitment to providing patients and adult-use consumers across New Jersey with innovative and carefully crafted cannabis products to enhance the everyday. The Company operates a cultivation and manufacturing facility in Boonton, New Jersey, and distributes its products via wholesale throughout the state in more than 100 dispensaries in addition to running its own three retail locations: Apothecarium Lodi, Apothecarium Maplewood, and Apothecarium Phillipsburg.
お知らせ • Apr 05TerrAscend Corp. to Report Q1, 2024 Results on May 09, 2024TerrAscend Corp. announced that they will report Q1, 2024 results After-Market on May 09, 2024
お知らせ • Feb 21TerrAscend Corp. to Report Fiscal Year 2023 Results on Mar 14, 2024TerrAscend Corp. announced that they will report fiscal year 2023 results After-Market on Mar 14, 2024
お知らせ • Jan 24TerrAscend Corp. Announces the Expansion of its Valhalla Product Offering to Include One of the First 100Mg Edibles in the Keystone StateTerrAscend Corp. announced the expansion of its Valhalla product offering to include one of the first 100mg edibles in The Keystone State. Valhalla's 100mg quick-acting, high-potency troches will land on store shelves on February 2nd. The Valhalla Extra Strength Troches will be available at all Apothecarium locations and additional dispensaries throughout Pennsylvania. The innovative Valhalla Troches first debuted in Pennsylvania last fall, quickly becoming a patient favorite. Currently available in 5mg, 10mg, and 50mg of THC flavor-forward varieties, including Blue Raspberry (Indica), Orange (Sativa), and Watermelon (Hybrid), Valhalla Troches are supplied in convenient, resealable packaging optimal for patients on the go. The new 100mg troches will be available in Grape (Indica), Pineapple (Sativa), and Green Apple (Hybrid).
お知らせ • Nov 11TerrAscend Corp. Raises Earnings Guidance for 2023TerrAscend Corp. is raising its outlook for Net Revenue and Adjusted EBITDA from continuing operations for 2023 to $320 million and $73 million, respectively, representing year-over-year growth of 29% in Net Revenue and 87% in Adjusted EBITDA from continuing operations, respectively. The full year 2023 increase in guidance implies 2023 fourth quarter Net Revenue of $89 million and Adjusted EBITDA from continuing operations1 of $24 million.
お知らせ • Oct 24TerrAscend Corp. to Report Q3, 2023 Results on Nov 09, 2023TerrAscend Corp. announced that they will report Q3, 2023 results After-Market on Nov 09, 2023
お知らせ • Aug 11+ 1 more updateTerrAscend Corp. Reports Impairment for the Second Quarter Ended June 30, 2023TerrAscend Corp. reported impairment results for the second quarter ended June 30, 2023. For the quarter, the company reported Impairment of property and equipment of $10,000.
お知らせ • Aug 03TerrAscend Corp. to Report Q2, 2023 Results on Aug 10, 2023TerrAscend Corp. announced that they will report Q2, 2023 results After-Market on Aug 10, 2023
お知らせ • Jul 11TerrAscend Corp. (CNSX:TER) acquired Herbiculture Inc. for $8.25 million.TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Herbiculture Inc. for $8.25 million on June 29, 2023. Under the terms of the agreement, TerrAscend will acquire Herbiculture for total consideration of $8.25 million (the "Transaction"), composed of $3 million in cash, with the remainder in a seller’s note. The transaction, which is expected to be immediately accretive to TerrAscend on an EBITDA and cashflow basis, has already been approved by the Maryland Cannabis Administration and is expected to close in the coming days. Herbiculture has a net revenue run rate of approximately $4.3 million. TerrAscend Corp. (CNSX:TER) completed the acquisition of Herbiculture Inc. on July 10, 2023.
お知らせ • Jun 29TerrAscend Corp. (CNSX:TER) completed the acquisition of Derby 1, LLC.TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Derby 1, LLC for $22.1 million on June 7, 2023. Under the terms of the agreement, TerrAscend will acquire Peninsula Alternative Health for total consideration of $22.1 million, including $1.5 million in cash, with the remainder in a combination of existing debt, a seller’s note, and stock. The transaction, which is expected to be immediately accretive to TerrAscend on an EBITDA and cashflow basis, is subject to customary closing conditions, including regulatory approval. As of June 19, 2023 regulatory board approved the deal. The acquisition is expected to close shortly. The transaction is expected to be immediately accretive to TerrAscend on an EBITDA and cashflow basis. TerrAscend Corp. (CNSX:TER) completed the acquisition of Derby 1, LLC on June 28, 2023.
お知らせ • Jun 28TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Hempaid, LLC for $6.8 million.TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Hempaid, LLC for $6.8 million on June 26, 2023. Under the terms of the agreement, TerrAscend will acquire Blue Ridge Wellness for total consideration of $6.75 million, including $3 million in cash, with the remainder in a seller’s note. Following the close of the Transaction, TerrAscend's retail footprint will increase to 36 dispensaries nationwide.
お知らせ • Jun 23TerrAscend Corp. announced that it expects to receive $15 million in fundingTerrAscend Corp. announced two concurrent private placements for the aggregate gross proceeds of $15 million. The private placements consist of an equity offering of up to 5,000,000 units at a price of $2 per unit for the gross proceeds of $7.5 million. Each unit is comprised of one common share of the Company and one-half of one Common Share purchase warrant. Each warrant will entitle the holder to acquire one common share from the company at a price of $1.95 per common share for a period of 24 months following the closing of the equity offering. The company is also offering approximately $7.5 million of debentures in the principal amount of $1,000 per debenture. Unless earlier repaid or converted, the outstanding principal and accrued and unpaid interest on the debentures will be due and payable 36 months following the closing of the debenture offering. Each debenture will bear interest at a rate of 9.9% per annum from the date of issuance, calculated and compounded semi-annually, and payable on the maturity date. The securities offered pursuant to the private placements have not been and will not be registered under the U.S. Securities Act of 1933, as amended. The first closing is expected to occur on June 22, 2023.
お知らせ • Jun 10TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Derby 1, LLC for $22.1 million.TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Derby 1, LLC for $22.1 million on June 7, 2023. Under the terms of the agreement, TerrAscend will acquire Peninsula Alternative Health for total consideration of $22.1 million, including $1.5 million in cash, with the remainder in a combination of existing debt, a seller’s note, and stock. The transaction, which is expected to be immediately accretive to TerrAscend on an EBITDA and cashflow basis, is subject to customary closing conditions, including regulatory approval.
お知らせ • May 24An unknown buyer acquired Facility located in Mississauga, Canada from TerrAscend Corp. (CNSX:TER) for CAD19.7 million.An unknown buyer acquired Facility located in Mississauga, Canada from TerrAscend Corp. (CNSX:TER) for CAD19.7 million on May 23, 2023.An unknown buyer completed the acquisition of Facility located in Mississauga, Canada from TerrAscend Corp. (CNSX:TER) on May 23, 2023.
お知らせ • Feb 15Terrascend Appoints Jeroen De Beijer as Chief People and Culture OfficerTerrAscend Corp. announced the appointment of Jeroen De Beijer as Chief People and Culture Officer, effective immediately. De Beijer brings more than 20 years of experience in global human resources and people management operations. De Beijer will manage TerrAscend's overall People team and strategy helping the Company scale all elements of its People organization, including culture, organizational design, talent acquisition, employee experience, operational efficiency and more. Most recently, DeBeijer worked as Vice President, Human Resources for Operations at Refresco, the world largest independent bottling company. In this role DeBeijer oversaw all Human Resources activities for Refresco North America's manufacturing facilities in the United States and Canada. DeBeijer transitioned into this role from his previous role in Refresco at their corporate head office in the Netherlands where he oversaw several international Human Resources projects and supported Refresco's Executive Board. Prior to his role at Refresco, DeBeijer owned his own consulting business focusing on Human Resources projects at large companies in the manufacturing and services industry. He also worked in leadership roles for Delta Lloyd, a large insurance company in the Netherlands, CapGemini Consulting and Nationale - Nederlanden, a large European Insurance company. DeBeijer began his Human Resources career as a consultant at Hay Group (now Korn/Ferry). Born in the Netherlands, DeBeijer received a master's degree in corporate and employment law from Utrecht University in the Netherlands.
お知らせ • Sep 03+ 1 more updateTerrAscend Corp. Brings its Premium California Brand, Valhalla Confections, to New JerseyTerrAscend Corp. announced the East Coast launch of its premium edibles brand Valhalla Confections. The THC-infused soft lozenges (the "soft lozenges") are exclusively available at the Company's two New Jersey Apothecarium dispensaries located in Maplewood and Phillipsburg. Valhalla's soft lozenges gained popularity on the West Coast as one of the first precisely dosed ingestible products on the market. The lozenges are gluten-free and formulated with THC oil, terpenes and cannabinoids to deliver precise, discreet and convenient cannabis experiences. At launch, New Jersey medical patients will have access to three of the brand's most popular flavors: Blue Raspberry, Sour Watermelon and Sweet Orange. Each package contains 35 lozenges, providing 10mg of THC per lozenge.
お知らせ • Aug 21TerrAscend Corp. (CNSX:TER) acquired an additional 12.5% stake in TerrAscend NJ LLC from Blue Marble Ventures, LLC and BWH NJ, LLC for $50 million.TerrAscend Corp. (CNSX:TER) acquired an additional 12.5% stake in TerrAscend NJ LLC from Blue Marble Ventures, LLC and BWH NJ, LLC for $50 million on August 20, 2021. As a part of the transaction, an initial cash payment of $25 million with an additional $25 million payment comprised of a combination of cash and common shares to be paid on or before December 31, 2021. As a result, the TerrAscend now owns 87.5% of the issued and outstanding equity of TerrAscend New Jersey. In addition, the TerrAscend and the sellers have agreed to terms whereby TerrAscend will have the option to purchase an additional 6.25% of TerrAscend New Jersey. TerrAscend Corp. (CNSX:TER) completed the acquisition of an additional 12.5% stake in TerrAscend NJ LLC from Blue Marble Ventures, LLC and BWH NJ, LLC on August 20, 2021.
お知らせ • May 20TerrAscend Corp. Raises Earnings Guidance for the Full Year 2021TerrAscend Corp. raised earnings guidance for the full year 2021. The company is raising full year guidance and expects net sales to exceed USD 300 million compared to previous guidance of USD 290 million.
お知らせ • May 04TerrAscend Corp. (CNSX:TER) completed the acquisition of GuadCo, LLC and KCR Holdings, LLC.TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire remaining 90% stake in GuadCo, LLC and KCR Holdings, LLC for $63 million on April 20, 2021. The consideration is comprised of $36 million in stock, $20.25 million in cash and a $6.75 million note. TerrAscend currently owns 10% of GuadCo and KCR. The purchase price is expected to represent a mid-single digit multiple of GuadCo and KCR's 2021 EBITDA. Upon close, the transaction will add three retail dispensaries located in Bethlehem, Allentown and Stroudsburg to complement TerrAscend’s existing retail footprint in Southeastern Pennsylvania. The transaction is subject to customary regulatory approvals and is expected to occur in the second quarter of 2021 and will be immediately accretive upon closing. TerrAscend Corp. (CNSX:TER) completed the acquisition of GuadCo, LLC and KCR Holdings, LLC on May 3, 2021.
お知らせ • Mar 24TerrAscend Corp. Provides Earnings Guidance for the Year of 2021TerrAscend Corp. provided earnings guidance for the year of 2021. For the year, the company expects net Sales to exceed USD 290 million.
お知らせ • Feb 20TerrAscend Corp. to Report Q4, 2020 Results on Mar 23, 2021TerrAscend Corp. announced that they will report Q4, 2020 results on Mar 23, 2021
お知らせ • Jan 13TerrAscend Corp. announced that it expects to receive CAD 223.727944 million in funding from Wasatch Advisors Inc.TerrAscend Corp. (CNSX:TER) announced an oversubscribed non-brokered private placement of 18,115,623 common shares at a price of CAD 12.35 per share gross proceeds of CAD 223,727,944 on January 12, 2021. The transaction includes 80% of commitment from four large U.S. institutional investors including Wasatch Advisors Inc. The transaction is subject to customary closing conditions, including applicable CSE approvals. The transaction is expected to close on or about January 26, 2021.
お知らせ • Nov 25TerrAscend Corp. Receives Permit to Dispense Medical Cannabis at its First New Jersey DispensaryTerrAscend Corp. ('TerrAscend') announced that it has received the final permit from the NJ Department of Health ("NJ DOH") to dispense medical cannabis from its first dispensary in New Jersey. The 3,500 square-foot dispensary, located at 55 South Main Street in downtown Phillipsburg, is situated in the historic Phillipsburg National Bank & Trust building and is the first Alternative Treatment Center ('ATC') in Warren County. The Apothecarium Phillipsburg will commence serving medical patients, by appointment only, followed by an official grand opening on November 30, 2020. The new full service medical dispensary offers a broad range of patient education resources, including multiple private consultation rooms and highly trained wellness consultation staff to assist patients and caregivers. TerrAscend operates a cultivation and manufacturing facility located in Boonton, New Jersey (the 'Boonton Facility') and expects to open three ATC's in the Northern region of New Jersey. New Jersey, which recently voted to legalize a forthcoming adult-use cannabis program, is the 11th large state in the U.S. by population, with nearly 9 million residents, and more than 94,000 registered medical cannabis patients. The Company expects to open the remaining two ATCs, or dispensaries in 2021 upon regulatory approval. The Northern region of New Jersey has the higher density of patients in the state, and TerrAscend is one of four permit holders. The Apothecarium Phillipsburg offers a wide variety of medical cannabis products, including dried flower, vaporizable and activated oils, pre-rolls, capsules, tinctures, topicals, and a comprehensive selection of smoking and ancillary products. Additionally, the new dispensary carries TerrAscend's recently launched Kind Tree branded cannabis products grown at the Company's Boonton Facility. Like other Apothecarium stores, the modern, tech-forward aesthetic is designed to be both comfortable and easy to navigate for seniors, first-time dispensary visitors, and patients with serious medical conditions. To comply with new state COVID-19 restrictions and CDC guidelines, in-person visits require pre-registration and only patients with appointments are permitted to shop in the store. The dispensary also offers online ordering and in-store pickup, with curbside pickup and delivery service launching shortly. All Apothecarium dispensaries have implemented strict safety standards to protect guests and team members. The Company's New Jersey safety protocols include strict social distancing inside and outside the dispensaries, a mask requirement for everyone inside the dispensaries, no contact check-in procedures and ongoing sanitizing throughout the day.
お知らせ • Nov 04TerrAscend Corp. to Report Q3, 2020 Results on Nov 19, 2020TerrAscend Corp. announced that they will report Q3, 2020 results at 12:27 PM, GMT Standard Time on Nov 19, 2020
お知らせ • Nov 03TerrAscend Corp. Announces Appointment of Ed Schutter to Its Board of DirectorsTerrAscend Corp. announced the appointment of Ed Schutter to its Board of Directors. Mr. Schutter is a seasoned executive with over thirty years of pharmaceutical industry experience. He currently serves as Chief Executive Officer of Arbor Pharmaceuticals. Arbor also has several branded prescription products in late stage development. Prior to joining Arbor, Ed served as President of Sciele (Shionogi) Pharmaceuticals.
お知らせ • Aug 22TerrAscend Corp. announced that it has received $37 million in funding from JW Asset Management, LLCIn the second quarter of 2020, TerrAscend Corp. (CNSX:TER) closed the transaction. The company received $2,586,000 in its final tranche.
お知らせ • Aug 07TerrAscend Corp. to Report Q2, 2020 Results on Aug 20, 2020TerrAscend Corp. announced that they will report Q2, 2020 results at 12:27 PM, GMT Standard Time on Aug 20, 2020